These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effect of halogenated substituents on the metabolism and estrogenic effects of the equine estrogen, equilenin. Liu X, Zhang F, Liu H, Burdette JE, Li Y, Overk CR, Pisha E, Yao J, van Breemen RB, Swanson SM, Bolton JL. Chem Res Toxicol; 2003 Jun; 16(6):741-9. PubMed ID: 12807357 [Abstract] [Full Text] [Related]
6. Relationship between type I and type II estrogen binding sites in the rat uterus. Moses DF, Fridman O, De Nicola AF. Acta Physiol Pharmacol Latinoam; 1985 Jun; 35(4):451-7. PubMed ID: 2940805 [Abstract] [Full Text] [Related]
8. [Thymidine kinase activity in mammary tumors of animals exposed to estradiol as an index of tumor hormone dependence]. Morozova TM, Plotnikova LIa. Vopr Onkol; 1982 Jun; 28(11):58-62. PubMed ID: 7147834 [Abstract] [Full Text] [Related]
9. In vivo estrogenic and antiestrogenic activity of phenolphthalein and derivative compounds. Nieto A, García C, López de Haro MS. Biochem Int; 1990 Jun; 21(2):305-11. PubMed ID: 2403370 [Abstract] [Full Text] [Related]
11. [Effect of 1,2-dimethylhydrazine on the level of specific binding and ligand affinity to the estradiol receptor in the cytosol of uterine tissue in CBA mice]. Morozova OV, Kushlinskiĭ NE. Eksp Onkol; 1987 Jun; 9(4):54-6. PubMed ID: 3678126 [Abstract] [Full Text] [Related]
13. Effects of estrogens P-1496 and P-1560 on the binding of estradiol with rat uterine estrogen receptors. Di Carlo F, Conti G, Reboani C, Racca S. Farmaco Sci; 1980 May; 35(5):425-9. PubMed ID: 7450040 [Abstract] [Full Text] [Related]
17. Activity of three selective estrogen receptor modulators on hormone-dependent responses in the mouse uterus and mammary gland. Crabtree JS, Peano BJ, Zhang X, Komm BS, Winneker RC, Harris HA. Mol Cell Endocrinol; 2008 Jun 11; 287(1-2):40-6. PubMed ID: 18367319 [Abstract] [Full Text] [Related]
18. Role of hepatic monooxygenases in generating estrogenic metabolites from methoxychlor and from its identified contaminants. Bulger WH, Feil VJ, Kupfer D. Mol Pharmacol; 1985 Jan 11; 27(1):115-24. PubMed ID: 3965923 [Abstract] [Full Text] [Related]
19. Estrogenic properties of 3,9-dihydroxybenz[a]anthracene, a potential metabolite of benz[a]anthracene. Schneider SL, Alks V, Morreal CE, Sinha DK, Dao TL. J Natl Cancer Inst; 1976 Dec 11; 57(6):1351-4. PubMed ID: 826653 [Abstract] [Full Text] [Related]